With another earnings season upon us, the Fool's health-care team is busy making sure investors know what to expect from their favorite companies this quarter, while also maintaining a focus on the long term.
In this video segment, health-care bureau chief Brenton Flynn discusses the upcoming earnings report from Abbott Labs and AbbVie . As Brenton notes, this is the last time that investors will see combined results from these now-separate companies.
Wondering about that new position in your portfolio? For some Abbott Labs shareholders, the new year brought with it a new company called AbbVie. Formerly Abbott's branded pharmaceuticals business, shares of the new stock were distributed to investors on Jan. 2. To help investors better understand the situation, The Fool has created a brand new premium report on both stocks. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this report by clicking here now.
The article Abbott and AbbVie's Last Hurrah originally appeared on Fool.com.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.